Stone, Gregg W <br/><br/>
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.  [electronic resource] 

 -  Lancet (London, England)  10 2018 
 - 1530-1540 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(18)32283-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorbable Implants<br/>Acute Coronary Syndrome--therapy<br/>Aged<br/>Biocompatible Materials<br/>Coronary Artery Disease--pathology<br/>Double-Blind Method<br/>Drug-Eluting Stents<br/>Everolimus--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Tissue Scaffolds<br/>Treatment Outcome